| 1 |
Cai Y, Li X, Han Q, Bai J, Zheng Q, Sun R, Liu R. Si-Ni-San improves experimental colitis by favoring Akkermensia colonization. J Ethnopharmacol 2023;305:116067. [PMID: 36586523 DOI: 10.1016/j.jep.2022.116067] [Reference Citation Analysis]
|
| 2 |
Pradhan D, Gulati G, Avadhani R, H M R, Soumya K, Kumari A, Gupta A, Dwivedi D, Kaushik JK, Grover S. Postbiotic Lipoteichoic acid of probiotic Lactobacillus origin ameliorates inflammation in HT-29 cells and colitis mice. Int J Biol Macromol 2023;236:123962. [PMID: 36907160 DOI: 10.1016/j.ijbiomac.2023.123962] [Reference Citation Analysis]
|
| 3 |
Assandri MH, Malamud M, Trejo FM, Serradell MDLA. S-layer proteins as immune players: tales from pathogenic and non-pathogenic bacteria. Current Research in Microbial Sciences 2023. [DOI: 10.1016/j.crmicr.2023.100187] [Reference Citation Analysis]
|
| 4 |
Yang Y, Li M, Liu Q, Zhao Q, Zeng J, Wang Q, Zhao Y, Du F, Chen Y, Shen J, Luo H, Wang S, Li W, Chen M, Li X, Wang F, Sun Y, Gu L, Xiao Z, Du Y, Wu X. Starch from Pueraria lobata and the amylose fraction alleviates dextran sodium sulfate induced colitis in mice. Carbohydr Polym 2023;302:120329. [PMID: 36604040 DOI: 10.1016/j.carbpol.2022.120329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Manna L, Rizzi E, Bafile E, Cappelleri A, Ruscica M, Macchi C, Podaliri Vulpiani M, Salini R, Rossi E, Panebianco C, Perri F, Pazienza V, Federici F. Lentilactobacillus kefiri SGL 13 and Andrographis paniculata alleviate dextran sulfate sodium induced colitis in mice. Front Nutr 2023;10:1072334. [PMID: 36860688 DOI: 10.3389/fnut.2023.1072334] [Reference Citation Analysis]
|
| 6 |
Michaels M, Madsen KL. Immunometabolism and microbial metabolites at the gut barrier: Lessons for therapeutic intervention in inflammatory bowel disease. Mucosal Immunol 2023;16:72-85. [PMID: 36642380 DOI: 10.1016/j.mucimm.2022.11.001] [Reference Citation Analysis]
|
| 7 |
Wang J, Zhao D, Lei Z, Ge P, Lu Z, Chai Q, Zhang Y, Qiang L, Yu Y, Zhang X, Li B, Zhu S, Zhang L, Liu CH. TRIM27 maintains gut homeostasis by promoting intestinal stem cell self-renewal. Cell Mol Immunol 2023;20:158-74. [PMID: 36596873 DOI: 10.1038/s41423-022-00963-1] [Reference Citation Analysis]
|
| 8 |
Wang Z, Yang L, Sun S. Effect of Intestinal Microbiota Transplantation on Intestinal Flora and Inflammatory Factor Levels in Patients with Ulcerative Colitis. Infect Drug Resist 2023;16:1183-91. [PMID: 36879853 DOI: 10.2147/IDR.S394614] [Reference Citation Analysis]
|
| 9 |
Shim JA, Ryu JH, Jo Y, Hong C. The role of gut microbiota in T cell immunity and immune mediated disorders. Int J Biol Sci 2023;19:1178-91. [PMID: 36923929 DOI: 10.7150/ijbs.79430] [Reference Citation Analysis]
|
| 10 |
Lin S, Zhao H, Xu C, Zhang P, Mei X, Jiang D. Sulfasalazine-loaded nanoparticles for efficient inflammatory bowel disease therapy via ROS-scavenging strategy. Materials & Design 2023;225:111465. [DOI: 10.1016/j.matdes.2022.111465] [Reference Citation Analysis]
|
| 11 |
Shi J, Wang Y, Cheng L, Wang J, Raghavan V. Gut microbiome modulation by probiotics, prebiotics, synbiotics and postbiotics: a novel strategy in food allergy prevention and treatment. Crit Rev Food Sci Nutr 2022;:1-17. [PMID: 36576159 DOI: 10.1080/10408398.2022.2160962] [Reference Citation Analysis]
|
| 12 |
Talapko J, Včev A, Meštrović T, Pustijanac E, Jukić M, Škrlec I. Homeostasis and Dysbiosis of the Intestinal Microbiota: Comparing Hallmarks of a Healthy State with Changes in Inflammatory Bowel Disease. Microorganisms 2022;10. [PMID: 36557658 DOI: 10.3390/microorganisms10122405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Zhang X, Ishikawa D, Ohkusa T, Fukuda S, Nagahara A. Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1068567] [Reference Citation Analysis]
|
| 14 |
Cornelia Lazăr D, Moacă E, Cornianu M, Tăban S, Faur A, Goldiș A. Efficiency of Treatment Targeted on Gut Microbiota in Inflammatory Bowel Diseases: Current Strategies and Perspectives. Benign Anorectal Disorders - An Update [Working Title] 2022. [DOI: 10.5772/intechopen.108664] [Reference Citation Analysis]
|
| 15 |
Thriene K, Stanislas V, Amend L, Strowig T, Michels KB. Assessment of the Gut Microbiota during Juice Fasting with and without Inulin Supplementation: A Feasibility Study in Healthy Volunteers. Foods 2022;11. [PMID: 36429265 DOI: 10.3390/foods11223673] [Reference Citation Analysis]
|
| 16 |
Gąsiorowska A, Romanowski M, Walecka-kapica E, Kaczka A, Chojnacki C, Padysz M, Siedlecka M, Bierła JB, Steinert RE, Cukrowska B. Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of a Randomized Double-Blind Placebo-Controlled Trial. JCM 2022;11:6587. [DOI: 10.3390/jcm11216587] [Reference Citation Analysis]
|
| 17 |
Caetano MAF, Castelucci P. Role of short chain fatty acids in gut health and possible therapeutic approaches in inflammatory bowel diseases. World J Clin Cases 2022; 10(28): 9985-10003 [DOI: 10.12998/wjcc.v10.i28.9985] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Niu M, Guo H, Cai J, Meng X. Bifidobacterium breve Alleviates DSS-Induced Colitis in Mice by Maintaining the Mucosal and Epithelial Barriers and Modulating Gut Microbes. Nutrients 2022;14:3671. [DOI: 10.3390/nu14183671] [Reference Citation Analysis]
|
| 19 |
He KJ, Dong JH, Ouyang XM, Huo YN, Cheng XS, Lin Y, Li Y, Gong G, Liu J, Ren JL, Guleng B. Glycerol monolaurate ameliorates DSS-induced acute colitis by inhibiting infiltration of Th17, neutrophils, macrophages and altering the gut microbiota. Front Nutr 2022;9:911315. [PMID: 36034889 DOI: 10.3389/fnut.2022.911315] [Reference Citation Analysis]
|
| 20 |
Fernandes D, Andreyev J. The Role of the Human Gut Microbiome in Inflammatory Bowel Disease and Radiation Enteropathy. Microorganisms 2022;10:1613. [DOI: 10.3390/microorganisms10081613] [Reference Citation Analysis]
|
| 21 |
Xiao F, Dong F, Li X, Li Y, Yu G, Liu Z, Wang Y, Zhang T. Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. Front Pharmacol 2022;13:902337. [DOI: 10.3389/fphar.2022.902337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Rodríguez-Pastén A, Pérez-Hernández N, Añorve-Morga J, Jiménez-Alvarado R, Cariño-Cortés R, Sosa-Lozada T, Fernández-Martínez E. The Activity of Prebiotics and Probiotics in Hepatogastrointestinal Disorders and Diseases Associated with Metabolic Syndrome. Int J Mol Sci 2022;23:7229. [PMID: 35806234 DOI: 10.3390/ijms23137229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Zhao Z, Xu S, Zhang W, Wu D, Yang G. Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications. Food Funct 2022;13:5914-24. [PMID: 35583304 DOI: 10.1039/d2fo00226d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 24 |
Mulinari Turin de Oliveira N, Barbosa da Luz B, Schneider VS, Barbosa da Costa Filho H, Sérgio de Araujo Sousa P, Fernanda de Paula Werner M, Henrique Loiola Ponte de Souza M, Almeida Rocha J, Antonio Duarte Nicolau L, Mach Côrtes Cordeiro L, Maria-ferreira D. Dietary polysaccharides from guavira pomace, a co-product from the fruit pulp industry, display therapeutic application in gut disorders. Food Research International 2022;156:111291. [DOI: 10.1016/j.foodres.2022.111291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Zawistowska-Rojek A, Tyski S. How to Improve Health with Biological Agents-Narrative Review. Nutrients 2022;14:1700. [PMID: 35565671 DOI: 10.3390/nu14091700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 26 |
Tian Y, Zhang D, Nakamura M. Biological Clock and Inflammatory Bowel Disease Review: From the Standpoint of the Intestinal Barrier. Gastroenterology Research and Practice 2022;2022:1-11. [DOI: 10.1155/2022/2939921] [Reference Citation Analysis]
|
| 27 |
Dong F, Xiao F, Li X, Li Y, Wang X, Yu G, Zhang T, Wang Y. Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice. J Transl Med 2022;20:33. [PMID: 35033121 DOI: 10.1186/s12967-022-03235-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 28 |
Li Z, Li Z, Zhu L, Dai N, Sun G, Peng L, Wang X, Yang Y. Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients With Ulcerative Colitis in Clinical Remission. Front Nutr 2021;8:778542. [PMID: 35028306 DOI: 10.3389/fnut.2021.778542] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 29 |
Yang S, Shang J, Liu L, Tang Z, Meng X. Strains producing different short-chain fatty acids alleviate DSS-induced ulcerative colitis by regulating intestinal microecology. Food Funct 2022. [DOI: 10.1039/d2fo01577c] [Reference Citation Analysis]
|
| 30 |
Lacerda DC, Trindade da Costa PC, Paulino do Nascimento LC, de Brito Alves JL. Probiotics for gastrointestinal health and disease treatment. Probiotics for Human Nutrition in Health and Disease 2022. [DOI: 10.1016/b978-0-323-89908-6.00022-4] [Reference Citation Analysis]
|
| 31 |
Hu Y, Ye Z, Wu M, She Y, Li L, Xu Y, Qin K, Hu Z, Yang M, Lu F, Ye Q. The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies. Front Med (Lausanne) 2021;8:766126. [PMID: 34966755 DOI: 10.3389/fmed.2021.766126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 32 |
Zhang Y, Xue X, Su S, Zhou H, Jin Y, Shi Y, Lin J, Wang J, Li X, Yang G, Philpott JR, Liang J. Patients and physicians' attitudes change on fecal microbiota transplantation for inflammatory bowel disease over the past 3 years. Ann Transl Med 2021;9:1619. [PMID: 34926663 DOI: 10.21037/atm-21-3683] [Reference Citation Analysis]
|
| 33 |
Martyniak A, Medyńska-Przęczek A, Wędrychowicz A, Skoczeń S, Tomasik PJ. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD. Biomolecules 2021;11:1903. [PMID: 34944546 DOI: 10.3390/biom11121903] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 34 |
Siddiqui MT, Cresci GAM. The Immunomodulatory Functions of Butyrate. J Inflamm Res 2021;14:6025-41. [PMID: 34819742 DOI: 10.2147/JIR.S300989] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 35 |
Maioli TU, Trindade LM, Souza A, Torres L, Andrade MER, Cardoso VN, Generoso SV. Non-pharmacologic strategies for the management of intestinal inflammation. Biomed Pharmacother 2022;145:112414. [PMID: 34808552 DOI: 10.1016/j.biopha.2021.112414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Niu W, Dong Y, Fu Z, Lv J, Wang L, Zhang Z, Huo J, Ju J. Effects of molecular weight of chitosan on anti-inflammatory activity and modulation of intestinal microflora in an ulcerative colitis model. Int J Biol Macromol 2021:S0141-8130(21)02422-3. [PMID: 34748786 DOI: 10.1016/j.ijbiomac.2021.11.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 37 |
Ghoneum M, Abdulmalek S. KDP, a Lactobacilli Product from Kimchi, Enhances Mucosal Immunity by Increasing Secretory IgA in Mice and Exhibits Antimicrobial Activity. Nutrients 2021;13:3936. [PMID: 34836191 DOI: 10.3390/nu13113936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 38 |
Caviglia GP, De Blasio F, Vernero M, Armandi A, Rosso C, Saracco GM, Bugianesi E, Astegiano M, Ribaldone DG. Efficacy of a Preparation Based on Calcium Butyrate, Bifidobacterium bifidum, Bifidobacterium lactis, and Fructooligosaccharides in the Prevention of Relapse in Ulcerative Colitis: A Prospective Observational Study. J Clin Med 2021;10:4961. [PMID: 34768480 DOI: 10.3390/jcm10214961] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 39 |
Tong L, Zhang X, Hao H, Liu Q, Zhou Z, Liang X, Liu T, Gong P, Zhang L, Zhai Z, Hao Y, Yi H. Lactobacillus rhamnosus GG Derived Extracellular Vesicles Modulate Gut Microbiota and Attenuate Inflammatory in DSS-Induced Colitis Mice. Nutrients 2021;13:3319. [PMID: 34684320 DOI: 10.3390/nu13103319] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 40 |
Zhou C, Zhou H, Zhang F, Hao L, Guo J. Active Ingredients and Potential Mechanisms of the Gan Jiang-Huang Qin-Huang Lian-Ren Shen Decoction against Ulcerative Colitis: A Network Pharmacology and Molecular Docking-Based Study. Evid Based Complement Alternat Med 2021;2021:1925718. [PMID: 34539797 DOI: 10.1155/2021/1925718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
